Literature DB >> 18025312

Up-regulation of the mucosal epidermal growth factor receptor gene in chronic rhinosinusitis and nasal polyposis.

Guo Qiang Ding1, Chun Quan Zheng, Shelly S Bagga.   

Abstract

OBJECTIVES: To investigate the expression of epidermal growth factor receptor (EGFR) messenger RNA (mRNA) in human sinus mucosa and to compare the expression of EGFR and EGF among patients with chronic rhinosinusitis (CRS), patients with CRS and nasal polyposis (CRS/NP), and a healthy control group.
DESIGN: Maxillary sinus ostia mucosa was harvested from patients undergoing endoscopic sinus surgery for CRS or CRS/NP and from patients undergoing surgery for non-CRS pathologic conditions (control group). The samples were analyzed using semiquantitative reverse transcription-polymerase chain reaction to detect mRNA of EGFR. Hematoxylin-eosin staining and immunofluorescent staining were used to localize EGFR and EGF in the sinus mucosa.
SETTING: Academic research. PARTICIPANTS: Three groups (CRS, CRS/NP, and control), each with 10 subjects, were enrolled in the present study. MAIN OUTCOME MEASURES: Area ratios of positive cells in the epithelia were compared among the CRS, CRS/NP, and control groups. In addition, eosinophils were counted in the subepithelial connective tissue in the 3 groups.
RESULTS: The level of EGFR mRNAs in the sinus mucosa of the CRS and CRS/NP groups was statistically significantly increased compared with that in the control group (P < .01), and no statistically significant difference was found between the sinus mucosa of the CRS group and that of the CRS/NP group (P < .01). On hematoxylin-eosin staining, hyperplasia and metaplasia of epithelial goblet cells were present in the sinus mucosa of the CRS and CRS/NP groups. Epidermal growth factor receptor was mainly expressed in goblet cells and basal cells and was weakly expressed in ciliated cells, while EGF expression was located in epithelial cells and in some inflammatory cells but not in goblet cells. In the control group, expression of EGFR and EGF was lower compared with that in the CRS and CRS/NP groups. No statistically significant area ratios of positive cells differences in staining of EGFR and EGF were found between the CRS group and the CRS/NP group (P > .05), whereas statistically significant differences were found between the control group and the 2 CRS groups (P < .01). The number of eosinophils was statistically significantly increased in the CRS/NP group compared with that in the CRS group (P < .01).
CONCLUSION: Up-regulation of the EGFR cascade may have an important role regarding mucus production in the sinus mucosa of patients with CRS and CRS/NP associated with hyperplasia and metaplasia of epithelial goblet cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025312     DOI: 10.1001/archotol.133.11.1097

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  8 in total

1.  Dysregulation of E-cadherin in chronic rhinosinusitis with nasal polyps.

Authors:  Weijia Kong; Junhua Wu; Yanjun Wang; Jianxin Yue; Song Zhang; Yanping Yu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-08-17

2.  Different expressions of erbB1/2 and tight junction proteins in hypertrophic inferior turbinates and nasal polyps.

Authors:  Khac-Hung Nguyen; Hideaki Suzuki; Tetsuro Wakasugi; Nobusuke Hohchi; Koichi Hashida; Toyoaki Ohbuchi
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-28       Impact factor: 2.503

3.  Potential Involvement of the Epidermal Growth Factor Receptor Ligand Epiregulin and Matrix Metalloproteinase-1 in Pathogenesis of Chronic Rhinosinusitis.

Authors:  Tetsuya Homma; Atsushi Kato; Masafumi Sakashita; Tetsuji Takabayashi; James E Norton; Lydia A Suh; Roderick G Carter; Kathleen E Harris; Anju T Peters; Leslie C Grammer; Jin-Young Min; Stephanie Shintani-Smith; Bruce K Tan; Kevin Welch; David B Conley; Robert C Kern; Robert P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  2017-09       Impact factor: 6.914

4.  The role of innate immunity in the pathogenesis of chronic rhinosinusitis.

Authors:  Andrew P Lane
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

5.  EGF Protects Epithelial Cells from Barrier Damage in Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Le Chen; Quan Liu; Zhuofu Liu; Han Li; Xiang Liu; Hongmeng Yu
Journal:  J Inflamm Res       Date:  2022-01-19

6.  Significance of susceptible gene expression profiles in nasal polyposis.

Authors:  De Yun Wang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-12-26       Impact factor: 3.372

7.  Decreased expression of CCL17 in the disrupted nasal polyp epithelium and its regulation by IL-4 and IL-5.

Authors:  Byoungjae Kim; Hyun-Ji Lee; Nu-Ri Im; Doh Young Lee; Ha Kyun Kim; Cha Young Kang; Il-Ho Park; Seung Hoon Lee; Heung-Man Lee; Sang Hag Lee; Seung-Kuk Baek; Tae Hoon Kim
Journal:  PLoS One       Date:  2018-05-10       Impact factor: 3.240

8.  Epidermal growth factor upregulates expression of MUC5AC via TMEM16A, in chronic rhinosinusitis with nasal polyps.

Authors:  Jian Jiao; Tao Zhang; Yu Zhang; Jingyun Li; Min Wang; Ming Wang; Ying Li; Xiangdong Wang; Luo Zhang
Journal:  Allergy Asthma Clin Immunol       Date:  2020-05-27       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.